Cryo-Cell International Stock (AMEX: CCEL)

Cryo-Cell International (AMEX:CCEL) Stock, Quote.Headers.trade-ideas

CRYO-CELL INTL INC

Cryo-Cell International

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

Alternative Asset Management Acquisition Corp

ATHX

AXTI

CCEL

CNTB

COCP

COMS

FAZE

FNHC

KALV

LTRY

MNTK

MOND

MRVI

OBLG

PBTS

QNGY

RLYB

SRAD

THTX

VSTM

WLDS

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday

Intraday Update

ALNA

AQST

AVCT

AZRE

BIAF

BPTS

BXRX

CLAQ

COUP

DBVT

FWBI

GIII

GKOS

GPCO

IMRA

KSPN

MCRB

MGAM

NBEV

NUTX

PATH

QNRX

SIDU

SLQT

SPRO

SQFT

UNAM

VCSA

VERU

Gainers


	Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.


Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday&#39;s Mid-Day Session

ABST

ADGI

APVO

AREB

ARGO

Adtalem Global Education Inc. Common Stock

ATGE

AVYA

BCDA

BTTR

CYRN

DCFC

DOCS

ECOL

ENPH

ERYP

FSRD

GRCL

HUBG

IFBD

JOBY

LFLY

MRSN

NEWR

POWL

QNST

SNDL

SOPA

USNA

ZSAN

Gainers


	US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.


40 Stocks Moving In Wednesday&#39;s Mid-Day Session

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International Inc

CRYO-CELL International GAAP EPS of -$1.14 misses by $1.26, revenue of $31.3M misses by $0.08M

Allen Klee, an analyst from Maxim Group, maintained the Buy rating on Cryo-Cell International (CCEL – Research Report). The associated price target...

Cryo-Cell International: A Buy Rating Anchored in Strong Gross Margins and Long-Term Growth Prospects

Cryo-Cell plans to explore strategic alternatives and spin-off its Celle Corp unit

Cryo-Cell International Inc (CCEL) has provided an announcement. Cryo-Cell International, Inc. has announced its intention to spin off its subsidia...

Cryo-Cell International Announces Strategic Subsidiary Spin-Off Plans

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Cryo-Cell International</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ccel-stock-quote/"><strong>CCEL</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Cryo-Cell International reported earnings per share of 7 cents. This was above the analyst estimate for EPS of -2 cents.</li><li>The company reported revenue of $7.85 million.</li><li>This was 1.01% worse than the analyst estimate for revenue of $7.93 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/ccel-stock-earnings-cryo-cell-international-for-q1-of-2024/">CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024

CRYO-CELL International GAAP EPS of $0.07 beats by $0.13, revenue of $7.85M misses by $0.1M

Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more

CRYO-CELL International GAAP EPS of $0.08 beats by $0.04, revenue of $8M beats by $0.05M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Cryo-Cell International</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ccel-stock-quote/"><strong>CCEL</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Cryo-Cell International reported earnings per share of 8 cents. This was above the analyst estimate for EPS of 4 cents.</li><li>The company reported revenue of $8.04 million.</li><li>This was 1.17% better than the analyst estimate for revenue of $7.95 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/07/ccel-stock-earnings-cryo-cell-international-for-q2-of-2024/">CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024

In a report released yesterday, Allen Klee from Maxim Group assigned a Buy rating to Cryo-Cell International (CCEL – Research Report). The company'...

Maxim Group Gives a Buy Rating to Cryo-Cell International (CCEL)

AFAR

AIRE

BSET

BSVN

BYRN

EDUC

EPAC

ERIC

ETWO

EVGR

FAST

FNGR

GDST

HELE

HIFS

KRUS

LEDS

LEXX

MANU

NRIX

NTIC

NVOS

PCYO

PSMT

UPXI

VIST

VOXX

WDFC

XAIR

Press Releases

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Accolade

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

ATI Physical Therapy, Inc. Class A Common Stock

ATI Physical Therapy

Biodesix

Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares)

Concord Medical Services

CareMax

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

InfuSystems Holdings

Kindly MD

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Nutex Health

Novo Integrated Sciences, Inc. - Common Stock

Novo Integrated Sciences

Ontrak

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Psychemedics

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

SHL Telemedicine Ltd - American Depositary Shares

SHL Telemedicine

Star Equity Holdings, Inc. - Common Stock

Star Equity Hldgs

Talkspace

Maxim Group

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Cryo-Cell International

Cryo-Cell International (CCEL) Forecast

Cryo-Cell International (AMEX:CCEL) Stock, Quote.Headers.trade-ideas